Clinical trial
Modulation of the Immune Response by AM3 Glycoconjugate.
NCT04987554 is registered in ClinicalTrials.gov with University of Valladolid as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Modulation of the Immune Response by AM3 Glycoconjugate.
- Lead sponsor
- University of Valladolid
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 1, 2021
- Completion date
- December 31, 2022
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sars-cov-2 infection